Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Tarveda Therapeutics revenue
Tarveda Therapeutics's revenue is $2.6 million.
What is Tarveda Therapeutics's revenue?
- Tarveda Therapeutics has 36 employees, and the revenue per employee ratio is $71,944.
- Tarveda Therapeutics peak revenue was $2.6M in 2024.
On this page
Zippi applies for you, and finds you a job.
Tarveda Therapeutics financing
Tarveda Therapeutics received early financing of $2.8M on 2012-01-06.
| Series | Round size | Date |
|---|---|---|
| Series A | $2.8M | 01/2012 |
| Series B | $21M | 12/2013 |
| Series Unknown | $1M | 03/2014 |
| Series B | $21M | 01/2015 |
| Series C | $38M | 01/2016 |
| Series D | $30M | 02/2017 |
| Series Unknown | $13.6M | 12/2019 |
| Undisclosed | $15.0M | 12/2020 |
| Series Unknown | $6.0M | 09/2021 |
Tarveda Therapeutics investors
| Investors | Security type |
|---|---|
| New Enterprise Associates (NEA) | Series A |
| NanoDimension | Series A |
| Flagship Pioneering Inc | Series A |
| New Enterprise Associates (NEA) | Series B |
| NanoDimension | Series B |
| Flagship Pioneering Inc | Series B |
| Eminent Venture Capital | Series B |
| New Enterprise Associates (NEA) | Series B |
| NanoDimension | Series B |
| Flagship Pioneering Inc | Series B |
| Novo Holdings A | Series C |
| New Enterprise Associates (NEA) | Series C |
| Novo Holdings A | Series D |
| New Enterprise Associates (NEA) | Series D |
| Versant Ventures | Series D |
| NanoDimension | Series D |
| Flagship Pioneering Inc | Series D |
Search for jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Tarveda Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Tarveda Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Tarveda Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Tarveda Therapeutics. The data presented on this page does not represent the view of Tarveda Therapeutics and its employees or that of Zippia.
Tarveda Therapeutics may also be known as or be related to Tarveda Therapeutics, Tarveda Therapeutics Inc and Tarveda Therapeutics, Inc.